<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Main indications for allogeneic bone marrow transplantation are severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo>, <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In standard risk situations survival rates are 50 to 80% </plain></SENT>
<SENT sid="2" pm="."><plain>The probability of disease-free survival after bone marrow transplantation is depending on the stage of disease </plain></SENT>
<SENT sid="3" pm="."><plain>If possible bone marrow transplantation should be performed early, not in advanced disease when conventional measures failed </plain></SENT>
<SENT sid="4" pm="."><plain>Main problems are therapy-related organ toxicity, rejection, <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> and a long lasting risk of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Usually histocompatible relatives of the patients are selected as marrow donors </plain></SENT>
<SENT sid="6" pm="."><plain>Bone marrow transplantation using unrelated donors is under investigation </plain></SENT>
<SENT sid="7" pm="."><plain>Autologous transplantations with cryopreserved marrow are performed in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and some <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>, but prospective studies comparing transplantation and conventional therapeutic procedures are still missing </plain></SENT>
</text></document>